Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
NRX Pharmaceuticals, Inc. - Common Stock
(NQ:
NRXP
)
3.535
-0.025 (-0.70%)
Streaming Delayed Price
Updated: 10:18 AM EDT, Aug 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about NRX Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
NRX Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call Transcript
↗
August 17, 2026
NRX Pharmaceuticals (NASDAQ:NRXP) released second-quarter financial results and hosted an earnings call on Monday. Read the complete transcript below. This content is powered by Benzinga APIs. For...
Via
Benzinga
Topics
Earnings
NRx Pharmaceuticals Nears FDA Decision on Preservative-Free Ketamine After Review Clears Hurdles
↗
August 10, 2026
NRx Pharmaceuticals (NASDAQ:NRXP) said it has completed the first-cycle U.S. Food and Drug Administration review of its abbreviated new drug application, or ANDA, for preservative-free ketamine, with...
Via
MarketBeat
These stocks are moving in today's pre-market session
↗
June 03, 2026
Via
Chartmill
What's going on in today's after hours session
↗
June 02, 2026
Via
Chartmill
Why Did NRXP Stock Surge 21% Pre-Market Today?
↗
January 14, 2026
Via
Stocktwits
Insights Ahead: NRX Pharmaceuticals's Quarterly Earnings
↗
August 13, 2025
Via
Benzinga
HOPE Therapeutics Secures Financing For Ketamine Clinic Expansion
↗
August 26, 2024
HOPE Therapeutics, Inc., a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP),
Via
Benzinga
NRx (NRXP) Q1 2026 Earnings Call Transcript
↗
May 27, 2026
NRx (NRXP) Q1 2026 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Tuesday's session: top gainers and losers
↗
May 26, 2026
Via
Chartmill
My Top 3 Biotech Stocks for May 2026
↗
May 20, 2026
As FDA activity accelerates and big pharma searches for its next generation of blockbuster drugs, select biotech companies are beginning to stand out from the crowd.
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
NRx Pharmaceuticals Q1 Earnings Call Highlights
↗
May 18, 2026
NRx Pharmaceuticals (NASDAQ:NRXP) said it advanced several regulatory, manufacturing and clinical initiatives during the first quarter of 2026, including progress toward potential approval of its...
Via
MarketBeat
Topics
Earnings
Earnings Scheduled For November 17, 2025
↗
November 17, 2025
Via
Benzinga
Earnings Outlook For NRX Pharmaceuticals
↗
November 14, 2025
Via
Benzinga
Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday
↗
October 30, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
August 22, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
August 19, 2025
Via
Benzinga
Why Small-Cap Biotech NRx Pharmaceuticals Is Drawing Heavy Retail Buzz
↗
August 12, 2025
NRx said the FDA’s fast-track status makes NRX-100 eligible for the Commissioner’s National Priority Voucher program and the FDA’s Accelerated Approval pathway, and the company has already applied for...
Via
Stocktwits
Uncovering Potential: NRX Pharmaceuticals's Earnings Preview
↗
May 14, 2025
Via
Benzinga
Stocktwits Spotlight: NRx, CVS, ReShape Lead Weekly Jump In Health Care Stock Chatter
↗
May 04, 2025
Favorable regulatory moves for a new drug application, blowout earnings and promising preclinical data triggered a flurry of discussions on Stocktwits for these tickers for the week ended April 11,...
Via
Stocktwits
Topics
Intellectual Property
Law Enforcement
Lawsuit
Earnings Scheduled For May 15, 2025
↗
May 15, 2025
Via
Benzinga
Amazon.com To $253? Here Are 10 Top Analyst Forecasts For Tuesday
↗
April 29, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
March 17, 2025
Via
Benzinga
Earnings Scheduled For March 17, 2025
↗
March 17, 2025
Via
Benzinga
Small-Cap NRx Pharma’s Stock Draws Heavy Retail Buzz After Securing $27M Funding
↗
January 29, 2025
Chairman Jonathan Javitt said the resources committed are expected to bring NRx to the $100 million revenue threshold.
Via
Stocktwits
What's Going On With NRX Pharmaceuticals Stock Tuesday?
↗
January 28, 2025
NRX Pharmaceuticals shares are moving higher on Tuesday after it invested $27 million in its subsidiary HOPE Therapeutics.
Via
Benzinga
What's Going On With NRX Pharmaceuticals Stock Thursday?
↗
January 02, 2025
NRX shares are trading higher on Thursday after the company announced a joint acquisition initiative with Hope Therapeutics to buy Kadima Neuropsychiatry Institute.
Via
Benzinga
Why MicroStrategy Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket
↗
January 02, 2025
Shares of MicroStrategy Incorporated (NASDAQ:MSTR) rose sharply in today's pre-market trading.
Via
Benzinga
NRXP Stock Earnings: NRX Pharmaceuticals Misses EPS for Q2 2024
↗
August 14, 2024
NRXP stock results show that NRX Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
May 16, 2024
Via
Benzinga
NRXP Stock Earnings: NRX Pharmaceuticals Misses EPS for Q1 2024
↗
May 14, 2024
NRXP stock results show that NRX Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
